BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matura LA, McDonough A, Carroll DL. Symptom Prevalence, Symptom Severity, and Health-Related Quality of Life Among Young, Middle, and Older Adults With Pulmonary Arterial Hypertension. Am J Hosp Palliat Care 2016;33:214-21. [PMID: 25294227 DOI: 10.1177/1049909114554079] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Hidayati F, Gharini PPR, Hartopo AB, Anggrahini DW, Dinarti LK. The effect of oral sildenafil therapy on health-related quality of life in adults with pulmonary arterial hypertension related to uncorrected secundum atrial septal defect: a quasi experimental study. Health Qual Life Outcomes 2020;18:278. [PMID: 32795300 DOI: 10.1186/s12955-020-01498-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Zhou X, Shi H, Yang Y, Zhang Z, Zhai Z, Wang C. Anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a Chinese survey. Exp Ther Med 2020;19:3124-32. [PMID: 32256800 DOI: 10.3892/etm.2020.8566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Khair RM, Nwaneri C, Damico RL, Kolb T, Hassoun PM, Mathai SC. The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension. Ann Am Thorac Soc 2016;13:842-9. [PMID: 26974862 DOI: 10.1513/AnnalsATS.201512-824OC] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
4 Tartavoulle TM, Karpinski AC, Aubin A, Kluger BM, Distler O, Saketkoo LA. Multidimensional fatigue in pulmonary hypertension: prevalence, severity and predictors. ERJ Open Res 2018;4:00079-2017. [PMID: 29577043 DOI: 10.1183/23120541.00079-2017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Von Visger TT, Thrane SE, Klatt MD, Dabbs AD, Chlan LL, Tan A, Happ MB. The Impact of Urban Zen Integrative Therapy on Symptoms and Health-Related Quality of Life for Patients with Pulmonary Hypertension. Journal of Palliative Medicine 2020;23:703-11. [DOI: 10.1089/jpm.2019.0359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Wilson M, Anguiano RH, Awdish RLA, Coons JC, Kimber A, Morrison M, Paulus S, Schmit A, Spexarth F, Swetz KM, Verlinden NJ, Whittenhall ME, Sketch MR, Broderick M, Brewer J. An expert panel Delphi consensus statement on the use of palliative care in the management of patients with pulmonary arterial hypertension. Pulm circ 2022;12. [DOI: 10.1002/pul2.12003] [Reference Citation Analysis]
7 Constantine A, Condliffe R, Clift P, Tulloh R, Dimopoulos K; CHAMPION Steering Committee. Palliative care in pulmonary hypertension associated with congenital heart disease: systematic review and expert opinion. ESC Heart Fail 2021;8:1901-14. [PMID: 33660435 DOI: 10.1002/ehf2.13263] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Tossavainen E, Henein MY, Grönlund C, Lindqvist P. Left Atrial Intrinsic Strain Rate Correcting for Pulmonary Wedge Pressure Is Accurate in Estimating Pulmonary Vascular Resistance in Breathless Patients. Echocardiography 2016;33:1156-65. [PMID: 27144613 DOI: 10.1111/echo.13226] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
9 Von Visger TT, Lee D, Lyons A, Chang YP. Integrated Review of Psychosocial and Behavioral Health Assessments and Interventions in Pulmonary Hypertension. Nurs Res 2021;70:150-61. [PMID: 33630538 DOI: 10.1097/NNR.0000000000000490] [Reference Citation Analysis]
10 McGoon MD, Ferrari P, Armstrong I, Denis M, Howard LS, Lowe G, Mehta S, Murakami N, Wong BA. The importance of patient perspectives in pulmonary hypertension. Eur Respir J 2019;53:1801919. [PMID: 30545977 DOI: 10.1183/13993003.01919-2018] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 16.3] [Reference Citation Analysis]
11 Małaczynska-Rajpold K, Smukowska-Gorynia A, Heaney A, McKenna SP, Janus M, Araszkiewicz A, Jankiewicz S, Slawek-Szmyt S, Tomaszewska I, Mularek-Kubzdela T. The Polish adaptation of the CAMbridge Pulmonary Hypertension Outcome Review (CAMPHOR). Cardiol J 2020;27:608-15. [PMID: 30338844 DOI: 10.5603/CJ.a2018.0119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Swiatek KM, Lester C, Ng N, Golia S, Pinson J, Grinnan D. Impact of Face Masks on 6-Minute Walk Test in Healthy Volunteers. Pulm Circ 2021;11:2045894020988437. [PMID: 33532062 DOI: 10.1177/2045894020988437] [Reference Citation Analysis]
13 Ivarsson B, Hesselstrand R, Rådegran G, Kjellström B. Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. Chron Respir Dis 2019;16:1479972318787906. [PMID: 30011997 DOI: 10.1177/1479972318787906] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
14 Zhai Z, Zhou X, Zhang S, Xie W, Wan J, Kuang T, Yang Y, Huang H, Wang C. The impact and financial burden of pulmonary arterial hypertension on patients and caregivers: results from a national survey. Medicine (Baltimore) 2017;96:e6783. [PMID: 28953608 DOI: 10.1097/MD.0000000000006783] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]